APEX Tech Files S-1/A, Details $473K Offering Expenses

TL;DR

**APEX Tech's S-1/A is a procedural step, but the $473,000 in offering expenses and strong insider commitment are key details for traders.**

AI Summary

APEX Tech Acquisition Inc. (TRAD-UN) filed an S-1/A on December 22, 2025, primarily as an exhibit-only amendment, indicating no fundamental changes to its core business model or financial statements. The filing details estimated offering expenses totaling $473,000, including $170,000 for legal fees and $70,000 for accounting fees, alongside a $140,000 reimbursement to underwriters. The company previously issued 1,725,000 initial shares to shareholders in September 2025 for $25,000, or approximately $0.0145 per share, under a Section 4(a)(2) exemption. Its sponsor is committed to purchasing 187,300 private units simultaneously with the offering, with an option for an additional 13,500 private units if the over-allotment is exercised. The S-1/A also includes consents from Zengwei Gao, Jiancheng Li, and Zheng Zeng, and reiterates the company's intent to indemnify officers and directors to the maximum extent permitted by Cayman Islands law, excluding actual fraud or willful neglect.

Why It Matters

This S-1/A filing provides crucial transparency on the cost structure of APEX Tech Acquisition Inc.'s public offering, with $473,000 in estimated expenses directly impacting the net proceeds available for future business combinations. Investors should note the significant indemnification provisions for directors and officers, which could influence risk assessment. The commitment from the sponsor to purchase 187,300 private units signals insider confidence, but the overall SPAC structure faces intense scrutiny in a competitive market where many SPACs struggle to find suitable targets. This amendment, while exhibit-only, confirms the ongoing process towards a public listing.

Risk Assessment

Risk Level: medium — The risk level is medium due to the inherent uncertainties of a SPAC, as highlighted by the 'Explanatory Note' stating the remainder of the Registration Statement is unchanged, implying core SPAC risks persist. While the filing details $473,000 in offering expenses, these are estimates and could increase, impacting the capital available for a business combination. The indemnification provisions for directors and officers, while common, also present a potential risk to the company's financial health in the event of legal challenges, as the SEC views such indemnification against public policy for Securities Act liabilities.

Analyst Insight

Investors should closely monitor the final prospectus for APEX Tech Acquisition Inc. to understand the definitive terms of the offering and the specific target acquisition criteria. Given the $473,000 in estimated offering expenses, assess the potential dilution and the impact on the company's ability to secure a high-quality business combination. Evaluate the sponsor's continued commitment through private unit purchases as a sign of confidence, but remain cautious about the broader SPAC market's performance.

Financial Highlights

total Assets

$0

cash Position

$0

total Debt

$0

Key Numbers

• $473,000 — Total estimated offering expenses (Represents the total estimated costs for the public offering, excluding underwriting discounts and commissions.)
• $170,000 — Legal fees and expenses (A significant portion of the total estimated offering expenses.)
• $70,000 — Accounting fees and expenses (Another substantial component of the total estimated offering expenses.)
• $140,000 — Reimbursement to underwriters for expenses (Part of the estimated offering expenses, paid to underwriters.)
• 1,725,000 — Initial shares issued (Issued to initial shareholders in September 2025.)
• $25,000 — Aggregate purchase price for initial shares (Paid by initial shareholders for 1,725,000 shares.)
• $0.0145 — Per share price for initial shares (The price at which initial shares were issued in September 2025.)
• 187,300 — Private units committed by sponsor (To be purchased simultaneously with the offering.)
• 13,500 — Additional private units option for sponsor (To be purchased if the over-allotment option is exercised by underwriters.)
• $10.00 — Price per private unit (The price at which the sponsor will purchase private units.)

Key Players & Entities

• APEX Tech Acquisition Inc. (company) — Registrant filing S-1/A
• Shaoren Liu (person) — Chief Executive Officer, Chief Financial Officer, and Director
• Venture Bridge Legal (company) — Agent for service and Authorized U.S. Representative
• Fei Pang (person) — Partner at Venture Bridge Legal and Authorized U.S. Representative
• Zengwei Gao (person) — Consenting individual for Exhibit 99.3
• Jiancheng Li (person) — Consenting individual for Exhibit 99.4
• Zheng Zeng (person) — Consenting individual for Exhibit 99.5
• SEC (regulator) — Securities and Exchange Commission
• Robinson & Cole LLP (company) — Legal counsel
• Cayman Islands (regulator) — Jurisdiction of incorporation

FAQ

Risk Factors

• Indemnification of Officers and Directors [medium — legal]: The company intends to indemnify its officers and directors to the maximum extent permitted by Cayman Islands law. This broad indemnification, while standard, could expose the company to significant financial liabilities in cases of alleged misconduct, excluding only actual fraud or willful neglect.

Industry Context

As a Special Purpose Acquisition Company (SPAC), APEX Tech Acquisition Inc. operates in a sector focused on identifying and merging with target companies, typically in the technology industry. The SPAC market is characterized by its reliance on market conditions for successful de-SPAC transactions and the ability to attract investor capital for both the initial offering and the subsequent merger. Regulatory scrutiny and investor sentiment heavily influence the success rates and valuations of SPACs.

Regulatory Implications

The S-1/A filing, even as an exhibit-only amendment, signifies ongoing compliance with SEC registration requirements. The company's commitment to indemnifying officers and directors, while standard, highlights potential legal and financial risks associated with corporate governance and executive actions. The use of Section 4(a)(2) for initial share issuance indicates a reliance on exemptions for private placements.

What Investors Should Do

1. Review Sponsor Commitment Details
2. Analyze Offering Expense Structure
3. Evaluate Indemnification Clauses

Key Dates

• 2025-09-01: Initial shares issued to shareholders — Established the initial share capital structure at a nominal price of $0.0145 per share, totaling $25,000 for 1,725,000 shares.
• 2025-12-22: S-1/A filing — An exhibit-only amendment, indicating no fundamental changes to the business model or financials, but detailing offering expenses and sponsor commitments.

Glossary

S-1/A

An amended registration statement filed with the SEC, used to update or correct information previously submitted in an S-1 filing. (This filing is an amendment to APEX Tech Acquisition Inc.'s initial registration statement, primarily for exhibit purposes.)

Underwriting Agreement

A contract between an issuer of securities and an underwriter, detailing the terms and conditions of the sale of securities. (Exhibit 1.1 outlines the terms of the agreement for the public offering, including potential reimbursements to underwriters.)

Private Placement Units

Units purchased by the sponsor or other private investors outside of the public offering, often at a different price or with different terms. (The sponsor is committed to purchasing 187,300 private units at $10.00 per unit, providing additional capital alongside the public offering.)

Section 4(a)(2) exemption

A provision in the Securities Act of 1933 that exempts from registration requirements certain transactions by an issuer not involving any public offering. (This exemption was used for the initial issuance of 1,725,000 shares to shareholders in September 2025.)

Indemnification Agreement

An agreement where one party agrees to protect another party against losses or damages. (Exhibit 10.5 details the company's commitment to indemnify its officers and directors, a common practice for SPACs.)

Year-Over-Year Comparison

This S-1/A filing is an exhibit-only amendment, indicating no material changes to the company's financial statements or core business model since the previous filing. The primary purpose appears to be the inclusion of updated or supplementary exhibits. Therefore, direct year-over-year comparisons of key financial metrics like revenue, margins, or net income are not applicable, as this amendment does not present updated financial performance data but rather procedural and contractual documentation.

Key Financial Figures

• $25,000 — ers, for an aggregate purchase price of $25,000, or approximately $0.0145 per share, in
• $0.0145 — hase price of $25,000, or approximately $0.0145 per share, in connection with the compa
• $10.00 — purchase from the company at a price of $10.00 per private unit up to an additional 13

Filing Documents

• appex_s1a.htm (S-1/A) — 98KB
• appex_ex11.htm (EX-1.1) — 229KB
• appex_ex993.htm (EX-99.3) — 3KB
• appex_ex994.htm (EX-99.4) — 3KB
• appex_ex995.htm (EX-99.5) — 3KB
• 0001477932-25-009136.txt ( ) — 337KB

Other Expenses of Issuance and Distribution

Item 13. Other Expenses of Issuance and Distribution. The estimated expenses payable by us in connection with the offering described in this registration statement (other than the underwriting discount and commissions) will be as follows: Initial trustee fee $ 6,000 Legal fees and expenses 170,000 Nasdaq listing fee 5,000 Printing and engraving expenses 2,500 Accounting fees and expenses 70,000 SEC registration fee 10,250 FINRA filing fee 9,594 Transfer agent fee 25,000 Reimbursement to underwriters for expenses 140,000 Miscellaneous (1) 34,656 Total $ 473,000 (1) This amount represents additional expenses that may be incurred by the company in connection with the offering over and above those specifically listed above, including other service fees and mailing costs.

Indemnification of Directors and Officers

Item 14. Indemnification of Directors and Officers. Cayman Islands law does not limit the extent to which a company's memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our post-offering amended and restated memorandum and articles of association will provide for indemnification of our officers and directors to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their own actual fraud, willful default or willful neglect. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is theretofore unenforceable.

Recent Sales of Unregistered Securities

Item 15. Recent Sales of Unregistered Securities. During the past three years, we sold the following ordinary shares without registration under the Securities Act: In September 2025, an aggregate of 1,725,000 initial shares were issued to our initial shareholders, for an aggregate purchase price of $25,000, or approximately $0.0145 per share, in connection with the company's organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. In addition, our sponsor has committed to purchasing an aggregate of 187,300 private units from the company on a private placement basis simultaneously with the consummation of this offering. Our sponsor has also agreed that if the over-allotment option is exercised by the underwriters in full or in part, they will purchase from the company at a price of $10.00 per private unit up to an additional 13,500 private units. These issuances will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No underwriting discounts or commissions were paid with respect to such sales. II-1 Table of Contents

Exhibits and Financial Statement Schedules

Item 16. Exhibits and Financial Statement Schedules. (a) The following exhibits are filed as part of this Registration Statement: Exhibit No. Description 1.1* Form of Underwriting Agreement 3.1*** Memorandum and Articles of Association 3.2*** Form of Amended and Restated Memorandum and Articles of Association 4.1*** Specimen Unit Certificate 4.2*** Specimen Ordinary Share Certificate 4.3*** Specimen Rights Certificate 4.4*** Form of Rights Agreement between Lucky Lucko, Inc. d/b/a Efficiency ("Efficiency") and the Registrant 5.1*** Opinion of Maples and Calder (Hong Kong) LLP 5.2*** Opinion of Venture Bridge Legal 10.1*** Form of Letter Agreement among the Registrant and the Company's officers, directors and Sponsor 10.2*** Form of Investment Management Trust Agreement between Lucky Lucko, Inc. d/b/a Efficiency ("Efficiency") and the Registrant 10.3*** Form of Registration Rights Agreement among the Registrant and the Insiders. 10.4*** Form of Private Placement Units Purchase Agreement between the Registrant and the Sponsor 10.5*** Form of Indemnification Agreement 10.6*** Founder Shares Subscription Agreement dated[], between the Registrant and the Sponsor 10.8*** Form of Employment Agreement 10.9*** Promissory Note, issued to the Sponsor, dated as of August 31, 2025 14*** Form of Code of Ethics. 23.1*** Consent of Simon & Edward LLP 23.2*** Consent of Venture Bridge Legal (included in Exhibit 5.2). 24* Power of Attorney (included on signature page) 99.1*** Form of Audit Committee Charter 99.2*** Form of Compensation Committee Charter 99.3* Consent of Zengwei Gao 99.4* Consent of Jiancheng Li 99.5* Consent of Zheng Zeng 99.6*** Form of Corporate Governance and Nominating Committee Charter 107*** Filing fee table * Filed herewith ** To be filed with an amendment. *** Previously Filed II-2 Table of Contents

Undertakings

Item 17. Undertakings. (a) The undersigned registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: i. To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; ii. To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement; iii. To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. (4) That for the purpose of determining any liability under the Securities Act of 1933 in a

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Dalian, China on December 22, 2025 APEX Tech Acquisition Inc. By: /s/ Shaoren Liu Name: Shaoren Liu Title: Chief Executive Officer and Chief Financial Officer Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities on on December 22, 2025 Name Position /s/ Shaoren Liu Chief Executive Officer, Chief Financial Officer and Director (Principal Executive, Financial and Accounting Officer Shaoren Liu AUTHORIZED U.S. REPRESENTATIVE Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of APEX Tech Acquisition Inc. has signed this registration statement in Los Angeles, California on on December 22, 2025 AUTHORIZED U.S. REPRESENTATIVE VENTURE BRIDGE LEGAL By: /s/ Fei Pang Name: Fei Pang Title: Partner II-5

View Full Filing

View this S-1/A filing on SEC EDGAR